SPRWF ~ HUGE potential for medical marijuana in Canada After receiving a patent approval, David's previous pharmaceutical company, Praxis Pharmaceuticals, received an equity investment from Rothschild Bioscience Unit, a division of the worldwide Rothschild Group. Source: http://www.thefreelibrary.com/Patent+Approval+by+Rothschild+Tele-Conference+Planned+for+July+15,...-a055155413 If people see David's affiliation with the world-renowned Rothschild Group, but fail to see the potential trajectory of Supreme Pharmaceuticals, they'll never know a good investment when they see it. Supreme Pharmaceuticals President and CEO David Stadnyk http://www.supremepharmaceuticals.com/index.php/corporate SPRWF is a gold mine and David & Co. will soon be passing out enormous nuggets to their shareholders. Read more about SPRWF at: http://investorshub.advfn.com/Supreme-Pharmaceuticals-Inc-SPRWF-19800/